Therapeutic upper endoscopy to identify and control active gastrointestinal bleeding is most often reported in the CPT code 43255. Since the management of bleeding can be an emergency treatment and may require more than one hemostatic method, coding needs to be based on careful procedural documentation and medical necessity.
Providers should thoroughly record the source of the bleeding, the method of hemostasis and the outcome of the treatment to facilitate correct coding. Comprehensive documentation minimises denials and facilitates reimbursement for these high-acuity gastroenterology services.
For practices that use Gastroenterology Billing Services, there can be structured coding review and documentation validation procedures that ensure the accuracy and compliance of their claims.
CPT 43255 Description
Official Definition:
"Esophagogastroduodenoscopy, flexible, transoral; with control of bleeding, any method."
CPT 43255 describes a therapeutic upper gastrointestinal endoscopy in which a flexible endoscope is advanced through the mouth to examine the esophagus, stomach, and duodenum while performing endoscopic treatment to control active or recent bleeding.
The physician may use any hemostatic method that can be employed, such as injection therapy, thermal coagulation, cautery, clip placement, topical agents, or a combination of these. A diagnostic EGD will be done as part of the procedure and should not be billed separately.
The service includes
- Flexible transoral esophagogastroduodenoscopy (EGD)
- Examination of the esophagus, stomach, and duodenum
- Identification of the bleeding source
- Endoscopic control of bleeding
- Injection therapy when performed
- Thermal coagulation or cautery techniques
- Mechanical clip placement
- Application of topical hemostatic agents
- Assessment of hemostasis following treatment
CPT 43255 does not include
- Separate reporting of the diagnostic EGD
- Treatment of bleeding that is incidental to another same-session procedure when separately reportable guidelines are not met
- Simple tissue biopsy
- Standard lesion removal procedures
- Endoscopic mucosal resection (EMR)
Clinical Indications for CPT 43255
CPT 43255 is used when therapeutic intervention with an endoscope is necessary for the upper gastrointestinal bleeding. This is often done in emergency and urgent situations to stop bleeding and loss of blood.
Common indications include
- Gastric bleeding caused by peptic ulcer.
- Esophageal variceal bleeding
- Gastric variceal bleeding
- Mallory-Weiss tears
- Dieulafoy lesions
- Gastrointestinal vascular malformations
- Bleeding gastrointestinal tumors
- Acute upper GI hemorrhage
- Hematemesis
- Melena
- Anemia associated with upper GI bleeding
The procedure is commonly performed after clinical evaluation identifies an upper gastrointestinal source requiring immediate hemostatic treatment.
Reimbursement Insights for CPT 43255
Reimbursement for CPT 43255 is usually greater than diagnostic upper endoscopy since it is a therapeutic procedure to treat active bleeding. Documentation of the bleeding source and how it was controlled is usually needed by payers.
Key reimbursement considerations
- Medicare and most commercial insurance policies will cover when medically necessary
- The reimbursement amount tends to be greater for reimbursement EGD services than diagnostic EGD services.
- Global period: 000 days
- CPT 43255 includes Diagnostic EGD.
- Payment is subject to payer contracts, geographic and place of service.
- Hospital outpatient departments and ASCs may receive separate facility reimbursement
- Medical necessity should be supported by appropriate bleeding-related diagnoses
- Documentation deficiencies may result in downcoding or claim denials
Applicable Modifiers for CPT 43255
Modifier selection should accurately reflect the circumstances surrounding the procedure and any additional services provided. Documentation must support all modifiers submitted on the claim.
Common modifiers
- Modifier -59 or X{EPSU}: If the bleeding control is a distinct procedural service performed in addition to another intervention in the same encounter.
- Modifier -22: Applied when bleeding management has significantly more effort, requires significantly more time, and/or is significantly more complex than it normally takes.
- Modifier -52: Used when the planned service is partially reduced.
- Modifier -53: Used when the procedure is discontinued due to patient safety concerns or technical limitations.
- Modifier -51: Any two or more procedures performed in the same session necessary for the payer to recover costs from the provider.
- Modifier -25: Applied to an evaluation and management service when a significant, separately identifiable E/M service is performed on the same day.
- Modifier -79: Used when an unrelated procedure is performed during the postoperative period.
Important billing rule
CPT 43255 should not be separately reported when bleeding control is performed solely to manage bleeding created by another endoscopic procedure during the same session unless payer guidelines specifically allow separate reporting.
Documentation Requirements for CPT 43255
- Medical indication to the procedure
- Describing symptoms and bleeding history.
- Bleeders: Bleeding source identified.
- The site of bleeding lesion
- The degree and type of bleeding.The amount and nature of bleeding.
- Most common method of hemostasis used
- Injection agents as needed
- The thermal and mechanical treatment information.
- Outcome of bleeding control
- Any complications encountered
- Patient tolerance of the procedure
- Signed final procedure report
Detailed documentation provides support for the therapeutic nature of the service and sets it apart from endoscopy.
Example Clinical Scenarios
Scenario 1: Bleeding Gastric Ulcer Requiring Endoscopic Hemostasis
A man comes to the Emergency Department with blood in his vomit and symptomatic anemia. An actively bleeding gastric ulcer is observed during the upper endoscopy. The gastroenterologist makes thermal coagulation and successfully obtains hemostasis.
→ Coding Outcome: CPT 43255
→ Rationale: Therapeutic endoscopic treatment was performed to control active upper gastrointestinal bleeding.
Scenario 2: Esophageal Variceal Hemorrhage
Acute upper GI bleed in a patient who has cirrhosis. Endoscopic treatment for esophageal varices to obtain hemostasis is performed when these are actively bleeding during EGD.
→ Coding Outcome: CPT 43255
→ Rationale: Endoscopic intervention for control of active variceal bleeding was performed.
Scenario 3: Dieulafoy Lesion Treated With Endoscopic Clips
Urgent upper endoscopy is performed in a patient with recurrent melena. The stomach is found to have a bleeding Dieulafoy lesion and several clips are used to halt the bleeding.
→ Coding Outcome: CPT 43255
→ Rationale: Mechanical hemostasis was used for controlling active gastrointestinal bleeding.
Scenario 4: Procedure Discontinued Due to Hemodynamic Instability
An EGD is performed in a patient with severe upper GI bleeding. As the procedure progresses, there is progressive hemodynamic instability that leads to the endoscopy being discontinued before adequate control of the bleed is achieved.
→ Coding Outcome: CPT 43255-53
→ Rationale: The procedure was discontinued due to patient safety concerns, supporting modifier -53.
BillingFreedom Maintaining Less Than 1% Preventable Denial Rates for GI Practices
BillingFreedom helps gastroenterology practices improve documentation quality and coding consistency for therapeutic endoscopic procedures. When services require the management of active bleeding, there is a need for thorough procedural reporting to be done in order to effectively support medical necessity and reimbursement processes.
Our team is dedicated to identifying missing documentation before claims are submitted and their accuracy and reducing unnecessary claim corrections and denials in practices. We facilitate smoother claims and more consistent reimbursement results in structured quality review processes.
Key Performance Indicators We Continuously Monitor
To ensure billing accuracy, it is important to continuously review the accuracy of documentation, coding, and the standards for payer compliance. So here is the BillingFreedom performance:
- A first pass claim acceptance of 97%–99%
- Avoidable denial rates kept under 1%
- Clean claim submission accuracy over 95%
- The internal coding validation accuracy is above 98%.
- Continuous Quality Assurance of documentation to minimize claim rework and resubmission
For more details about our Gastroenterology medical billing services, please don't hesitate to contact us by email at info@billingfreedom.com or call us at +1 (855) 415-3472.
It is our top priority to give you financial peace of mind!
Related ICD-10-CM Codes
ICD-10-CM Codes
C15.5 - Malignant neoplasm of lower third of esophagus
C15.8 - Malignant neoplasm of overlapping sites of esophagus
C15.9 - Malignant neoplasm of esophagus, unspecified
C16.1 - Malignant neoplasm of fundus of stomach
C16.2 - Malignant neoplasm of body of stomach
C16.5 - Malignant neoplasm of lesser curvature of stomach, unspecified
C16.6 - Malignant neoplasm of greater curvature of stomach, unspecified
C16.9 - Malignant neoplasm of stomach, unspecified
C18.7 - Malignant neoplasm of sigmoid colon
C7A.092 - Malignant carcinoid tumor of the stomach
C7A.094 - Malignant carcinoid tumor of the foregut, unspecified
C7B.02 - Secondary carcinoid tumors of liver
D12.0 - Benign neoplasm of cecum
D12.1 - Benign neoplasm of appendix
D12.2 - Benign neoplasm of ascending colon
D12.3 - Benign neoplasm of transverse colon
D12.4 - Benign neoplasm of descending colon
D12.5 - Benign neoplasm of sigmoid colon
D12.6 - Benign neoplasm of colon, unspecified
D13.1 - Benign neoplasm of stomach
D13.99 - Benign neoplasm of ill-defined sites within the digestive system
D3A.010 - Benign carcinoid tumor of the duodenum
D3A.011 - Benign carcinoid tumor of the jejunum
D3A.012 - Benign carcinoid tumor of the ileum
D3A.094 - Benign carcinoid tumor of the foregut, unspecified
F50.010 - Anorexia nervosa, restricting type, mild
F50.011 - Anorexia nervosa, restricting type, moderate
F50.012 - Anorexia nervosa, restricting type, severe
F50.013 - Anorexia nervosa, restricting type, extreme
F50.014 - Anorexia nervosa, restricting type, in remission
F50.019 - Anorexia nervosa, restricting type, unspecified
F50.020 - Anorexia nervosa, binge eating/purging type, mild
F50.021 - Anorexia nervosa, binge eating/purging type, moderate
F50.022 - Anorexia nervosa, binge eating/purging type, severe
F50.023 - Anorexia nervosa, binge eating/purging type, extreme
F50.024 - Anorexia nervosa, binge eating/purging type, in remission
F50.029 - Anorexia nervosa, binge eating/purging type, unspecified
F50.20 - Bulimia nervosa, unspecified
F50.21 - Bulimia nervosa, mild
F50.22 - Bulimia nervosa, moderate
F50.23 - Bulimia nervosa, severe
F50.24 - Bulimia nervosa, extreme
F50.25 - Bulimia nervosa, in remission
F50.810 - Binge eating disorder, mild
F50.811 - Binge eating disorder, moderate
F50.812 - Binge eating disorder, severe
F50.813 - Binge eating disorder, extreme
F50.814 - Binge eating disorder, in remission
F50.819 - Binge eating disorder, unspecified
F50.83 - Pica in adults
F50.84 - Rumination disorder in adults
F98.21 - Rumination disorder of infancy and childhood
J86.0 - Pyothorax with fistula
K21.9 - Gastro-esophageal reflux disease without esophagitis
K22.11 - Ulcer of esophagus with bleeding
K22.89 - Other specified disease of esophagus
K22.9 - Disease of esophagus, unspecified
K23 - Disorders of esophagus in diseases classified elsewhere
K25.0 - Acute gastric ulcer with hemorrhage
K25.1 - Acute gastric ulcer with perforation
K25.2 - Acute gastric ulcer with both hemorrhage and perforation
K25.4 - Chronic or unspecified gastric ulcer with hemorrhage
K25.5 - Chronic or unspecified gastric ulcer with perforation
K25.6 - Chronic or unspecified gastric ulcer with both hemorrhage and perforation
K25.7 - Chronic gastric ulcer without hemorrhage or perforation
K27.1 - Acute peptic ulcer, site unspecified, with perforation
K27.3 - Acute peptic ulcer, site unspecified, without hemorrhage or perforation
K27.4 - Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage
K27.5 - Chronic or unspecified peptic ulcer, site unspecified, with perforation
K27.6 - Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation
K27.9 - Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
K29.31 - Chronic superficial gastritis with bleeding
K29.41 - Chronic atrophic gastritis with bleeding
K29.51 - Unspecified chronic gastritis with bleeding
K29.71 - Gastritis, unspecified, with bleeding
K29.91 - Gastroduodenitis, unspecified, with bleeding
K31.7 - Polyp of stomach and duodenum
K55.21 - Angiodysplasia of colon with hemorrhage
K56.600 - Partial intestinal obstruction, unspecified as to cause
K56.601 - Complete intestinal obstruction, unspecified as to cause
K56.609 - Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction
K63.5 - Polyp of colon
K63.81 - Dieulafoy lesion of intestine
K70.10 - Alcoholic hepatitis without ascites
K70.11 - Alcoholic hepatitis with ascites
K70.40 - Alcoholic hepatic failure without coma
K70.41 - Alcoholic hepatic failure with coma
K70.9 - Alcoholic liver disease, unspecified
K73.0 - Chronic persistent hepatitis, not elsewhere classified
K74.00 - Hepatic fibrosis, unspecified
K74.01 - Hepatic fibrosis, early fibrosis
K74.02 - Hepatic fibrosis, advanced fibrosis
K74.1 - Hepatic sclerosis
K74.2 - Hepatic fibrosis with hepatic sclerosis
K74.3 - Primary biliary cirrhosis
K74.4 - Secondary biliary cirrhosis
K74.5 - Biliary cirrhosis, unspecified
K74.60 - Unspecified cirrhosis of liver
K74.69 - Other cirrhosis of liver
K75.4 - Autoimmune hepatitis
K75.81 - Nonalcoholic steatohepatitis (NASH)
K76.0 - Fatty (change of) liver, not elsewhere classified
K76.89 - Other specified diseases of liver
K76.9 - Liver disease, unspecified
K92.1 - Melena
K92.2 - Gastrointestinal hemorrhage, unspecified
Q85.82 - Other Cowden syndrome
Q85.83 - Von Hippel-Lindau syndrome
Q85.89 - Other phakomatoses, not elsewhere classified
R10.20 - Pelvic and perineal pain unspecified side
R10.21 - Pelvic and perineal pain right side
R10.22 - Pelvic and perineal pain left side
R10.23 - Pelvic and perineal pain bilateral
R10.24 - Suprapubic pain
R10.85 - Abdominal pain of multiple sites
R11.14 - Bilious vomiting
R19.5 - Other fecal abnormalities
T18.3XXD - Foreign body in small intestine, subsequent encounter
T18.3XXS - Foreign body in small intestine, sequela
T18.8XXD - Foreign body in other parts of alimentary tract, subsequent encounter
T18.9XXD - Foreign body of alimentary tract, part unspecified, subsequent encounter
T18.9XXS - Foreign body of alimentary tract, part unspecified, sequela
T54.1X1D - Toxic effect of other corrosive organic compounds, accidental (unintentional), subsequent encounter
T54.1X1S - Toxic effect of other corrosive organic compounds, accidental (unintentional), sequela
T54.1X2D - Toxic effect of other corrosive organic compounds, intentional self-harm, subsequent encounter
T54.1X2S - Toxic effect of other corrosive organic compounds, intentional self-harm, sequela
T54.1X3D - Toxic effect of other corrosive organic compounds, assault, subsequent encounter
T54.1X3S - Toxic effect of other corrosive organic compounds, assault, sequela
T54.1X4D - Toxic effect of other corrosive organic compounds, undetermined, subsequent encounter
T54.1X4S - Toxic effect of other corrosive organic compounds, undetermined, sequela
T54.2X1D - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), subsequent encounter
T54.2X1S - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), sequela
T54.2X2D - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, subsequent encounter
T54.2X2S - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, sequela
T54.2X3D - Toxic effect of corrosive acids and acid-like substances, assault, subsequent encounter
T54.2X3S - Toxic effect of corrosive acids and acid-like substances, assault, sequela
T54.2X4D - Toxic effect of corrosive acids and acid-like substances, undetermined, subsequent encounter
T54.2X4S - Toxic effect of corrosive acids and acid-like substances, undetermined, sequela
T54.3X1D - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), subsequent encounter
T54.3X1S - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), sequela
T54.3X2D - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, subsequent encounter
T54.3X2S - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, sequela
T54.3X3D - Toxic effect of corrosive alkalis and alkali-like substances, assault, subsequent encounter
T54.3X3S - Toxic effect of corrosive alkalis and alkali-like substances, assault, sequela
T54.3X4D - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, subsequent encounter
T54.3X4S - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, sequela
T54.91XD - Toxic effect of unspecified corrosive substance, accidental (unintentional), subsequent encounter
T54.91XS - Toxic effect of unspecified corrosive substance, accidental (unintentional), sequela
T54.92XD - Toxic effect of unspecified corrosive substance, intentional self-harm, subsequent encounter
T54.92XS - Toxic effect of unspecified corrosive substance, intentional self-harm, sequela
T54.93XD - Toxic effect of unspecified corrosive substance, assault, subsequent encounter
T54.93XS - Toxic effect of unspecified corrosive substance, assault, sequela
T54.94XD - Toxic effect of unspecified corrosive substance, undetermined, subsequent encounter
T54.94XS - Toxic effect of unspecified corrosive substance, undetermined, sequela
T57.1X1D - Toxic effect of phosphorus and its compounds, accidental (unintentional), subsequent encounter
T57.1X1S - Toxic effect of phosphorus and its compounds, accidental (unintentional), sequela
T57.1X2D - Toxic effect of phosphorus and its compounds, intentional self-harm, subsequent encounter
T57.1X2S - Toxic effect of phosphorus and its compounds, intentional self-harm, sequela
T57.1X3D - Toxic effect of phosphorus and its compounds, assault, subsequent encounter
T57.1X3S - Toxic effect of phosphorus and its compounds, assault, sequela
T57.1X4D - Toxic effect of phosphorus and its compounds, undetermined, subsequent encounter
T57.1X4S - Toxic effect of phosphorus and its compounds, undetermined, sequela
T65.5X1D - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), subsequent encounter
T65.5X1S - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), sequela
T65.5X2D - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, subsequent encounter
T65.5X2S - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, sequela
T65.5X3D - Toxic effect of nitroglycerin and other nitric acids and esters, assault, subsequent encounter
T65.5X3S - Toxic effect of nitroglycerin and other nitric acids and esters, assault, sequela
T65.5X4D - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, subsequent encounter
T65.5X4S - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, sequela
Z86.003 - Personal history of in-situ neoplasm of oral cavity, esophagus and stomach
Z86.004 - Personal history of in-situ neoplasm of other and unspecified digestive organs
Related CPT Codes
CPT Codes
43244 - Complete Billing & Coding Guide for EGD with Band Ligation of Esophageal and Gastric Varices
43245 - Complete Billing & Coding Guide for EGD with Dilation of Gastric or Duodenal Strictures
43248 - Complete Billing & Coding Guide for EGD with Guidewire-Assisted Esophageal Dilation
43249 - Complete Billing & Coding Guide for EGD With Esophageal Balloon Dilation
43251 - Complete Billing & Coding Guide for EGD With Snare Removal of Lesions
43254 - Complete Billing & Coding Guide for Endoscopic Mucosal Resection (EMR)
43239 - Complete Billing & Coding Guide for EGD with Biopsy
45380 - Complete Billing & Coding Guide for Colonoscopy with Biopsy